Citius Oncology, Inc. (CTOR) is a drug manufacturers - specialty & generic company listed on US.
Latest reported CTOR revenue for 2026-06-30 was $7.1M. Net income was -$41.1M. Revenue was up 26.6% from 2026-03-31 to 2026-06-30. CTOR currently screens at market cap $105.2M.
Use this CTOR page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the CTOR quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the CTOR SEC filings page. Lician reads the product cache first so this HTML stays unique to Citius Oncology, Inc. even when a live quote feed is slow.
Latest cached year on this hub. Full CTOR income, balance, and cash tables.